{"id":56,"date":"2019-01-23T05:40:10","date_gmt":"2019-01-23T05:40:10","guid":{"rendered":"http:\/\/demo.sparklewpthemes.com\/medicalheed\/?page_id=56"},"modified":"2021-09-20T13:45:43","modified_gmt":"2021-09-20T13:45:43","slug":"blood-bank","status":"publish","type":"page","link":"http:\/\/www.filiptashan.com\/blood-bank\/","title":{"rendered":"HPV &#038; Genital Si\u011filler"},"content":{"rendered":"\n<p>1. HPV bula\u015fmas\u0131 ile kanserle\u015fme s\u00fcresi aras\u0131ndaki ili\u015fki nedir?<\/p>\n\n\n\n<p>\u00b7 HPV bula\u015fmas\u0131 sonras\u0131nda aylar i\u00e7erisinde CIN ortaya \u00e7\u0131kabilmektedir.<\/p>\n\n\n\n<p>\u00b7 CIN3\u00fcn invazif kansere d\u00f6n\u00fc\u015f\u00fcm\u00fc ortalama 10 y\u0131l (8.1-12.6) s\u00fcrmektedir.<\/p>\n\n\n\n<p>\u00b7 Normale d\u00f6nme, CIN1 vakalar\u0131n\u0131n %60\u0131nda, CIN2lerin ise %40\u0131nda g\u00f6r\u00fclmektedir.<\/p>\n\n\n\n<p>2. HPV-DNA testi kimlere yap\u0131lmal\u0131d\u0131r?<\/p>\n\n\n\n<p>1. Aktif cinsel ya\u015fam\u0131n ba\u015flang\u0131c\u0131ndan sonraki \u00fc\u00e7\u00fcnc\u00fc y\u0131ldan itibaren tarama ama\u00e7l\u0131 olarak yap\u0131lmal\u0131 ve her \u00fc\u00e7 y\u0131lda bir kez tekrarlanmal\u0131d\u0131r (American Cancer Society, 2004).<\/p>\n\n\n\n<p>2. Pop-smearde ASC-US\/LSIL saptanmas\u0131 sonras\u0131nda kolposkopi endikasyonunun belirlenmesinde<\/p>\n\n\n\n<p>3. Tedavi sonrasinda HPV pozitifli\u011finin takibinde kullan\u0131lmaktad\u0131r.<\/p>\n\n\n\n<p>3. HPV materyali (s\u00fcr\u00fcnt\u00fc) nas\u0131l al\u0131nmal\u0131d\u0131r?<\/p>\n\n\n\n<p>Smear f\u0131r\u00e7as\u0131 servikse yerle\u015ftirilir ve saat y\u00f6n\u00fcnde 5-6 kez \u00e7evrilerek s\u00fcr\u00fcnt\u00fc al\u0131n\u0131r, m\u00fcmk\u00fcn oldu\u011funca fazla d\u00f6k\u00fcnt\u00fc almaya \u00e7al\u0131\u015f\u0131lmal\u0131d\u0131r. Daha sonra smear \u00e7ubu\u011funun f\u0131r\u00e7as\u0131 \u00f6zel sol\u00fcsyonu i\u00e7ine b\u0131rak\u0131lmal\u0131 ve en k\u0131sa zamanda ilgili molek\u00fcler tan\u0131 merkezine g\u00f6nderilmelidir.<\/p>\n\n\n\n<p>4. HPV DNA testinin (-) prediktif de\u011ferinin % 99 olmas\u0131 ne anlam ifade eder?<\/p>\n\n\n\n<p>HPV DNA test sonucunun negatif (-) olmas\u0131 CIN2\/CIN3 olas\u0131l\u0131\u011f\u0131n\u0131 %99 olas\u0131l\u0131kla d\u0131\u015flamakta, prekanser\u00f6z lezyon mevcudiyetinin de\u011ferlendirilmesinde ve kolposkopi endikasyonunun belirlenmesinde hekime \u00e7ok \u00f6nemli bilgiler sa\u011flamaktad\u0131r. Sonucun negatif bulunmas\u0131 ya da d\u00fc\u015f\u00fck riskli tiplerin tespit edilmi\u015f olmas\u0131 gereksiz pek \u00e7ok i\u015flem olas\u0131l\u0131\u011f\u0131n\u0131 ortadan kald\u0131rmaktad\u0131r.<\/p>\n\n\n\n<p>5. Pap smear ve HPV-DNA testi negatif (-) olan ki\u015fi bir daha ne zaman tarama yapt\u0131rmal\u0131d\u0131r?<\/p>\n\n\n\n<p>ACS (American Cancer Society) ve ASCCP (American Society for Colposcopy and Cervical Pathology)nin ortak karar\u0131na g\u00f6re 3 y\u0131ldan \u00f6nce Pap smear ve HPV-DNA testinin tekrarlanmas\u0131 gerekli g\u00f6r\u00fclmemektedir.<\/p>\n\n\n\n<p>6. Pap smear negatif (-) HPV DNA pozitif (+) ise ne yap\u0131lmal\u0131d\u0131r?<\/p>\n\n\n\n<p>ACS ve ASCCPe g\u00f6re 6 ay sonra Pap smear ve HPV DNA testi tekrar edilmelidir.<\/p>\n\n\n\n<p>7. Alt\u0131 ay sonra yap\u0131lan HPV DNA testi tekrarpozitif (+) \u00e7\u0131karsa ne yap\u0131lmal\u0131d\u0131r?<\/p>\n\n\n\n<p>ACS ve ASCCPye g\u00f6re Pap smear sonucunun negatif (-) olmas\u0131na ra\u011fmen HPV-DNA testinin pozitif (+) olmas\u0131 nedeniyle kolposkopiye gidilmelidir.<\/p>\n\n\n\n<p>8. Pap smear pozitif (+) ve HPV-DNA pozitif (+) ise ne yap\u0131lmal\u0131d\u0131r?<\/p>\n\n\n\n<p>ACS ve ASCCP ye g\u00f6re direkt kolposkopi \u00f6nerilmelidir.<\/p>\n\n\n\n<p>9. HPV vir\u00fcs\u00fcn\u00fcn di\u011fer kanserlerle de ili\u015fkisi var m\u0131d\u0131r?<\/p>\n\n\n\n<p>HPV 16 y\u00fcksek riskli genotipinin an\u00fcs, vulva, vagina ve penis gibi di\u011fer anogenital kanserlerle de ili\u015fkili oldu\u011fu tespit edilmi\u015ftir. Ayr\u0131ca respiratuar ve gastrointestinal traktuslarda da HPV ile ili\u015fkili baz\u0131 kanserler saptanm\u0131\u015ft\u0131r.<\/p>\n\n\n\n<p>10. A\u015f\u0131 hayat boyu koruma sa\u011flar m\u0131?<\/p>\n\n\n\n<p>A\u015f\u0131 uygulamas\u0131 yap\u0131lm\u0131\u015f kad\u0131nlarda bile servikal kanser tarama programlar\u0131n\u0131n hayat boyu devam ettirilmesi \u00f6nerilmektedir.(14)<\/p>\n\n\n\n<p>11. Neden tarama testleri yapt\u0131r\u0131lmal\u0131d\u0131r?<\/p>\n\n\n\n<p>Kanser kaynakl\u0131 kad\u0131n \u00f6l\u00fcmlerinde 2. s\u0131rada bulunan serviks kanseri erken tan\u0131 metodlar\u0131 kullan\u0131larak erken safhada yakalanabilmektedir. DNA tabanl\u0131 testlerin kullan\u0131m\u0131 ile tarama testlerinde ciddi mesafeler al\u0131nm\u0131\u015f durumdad\u0131r. \u00c7ok kolay uygulanabilen bu tekniklerin kullan\u0131m\u0131yla d\u00fc\u015f\u00fck maliyetlerle ciddi koruyucu hekimlik hizmeti verilebilmekte ve erken te\u015fhisin hasta, hekim ve sa\u011fl\u0131k sistemi a\u00e7\u0131s\u0131ndan t\u00fcm maddi ve manevi avantajlar\u0131na olanak sa\u011flanmaktad\u0131r.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>1. HPV bula\u015fmas\u0131 ile kanserle\u015fme s\u00fcresi aras\u0131ndaki ili\u015fki nedir? \u00b7 HPV bula\u015fmas\u0131 sonras\u0131nda aylar i\u00e7erisinde CIN ortaya \u00e7\u0131kabilmektedir. \u00b7 CIN3\u00fcn invazif kansere d\u00f6n\u00fc\u015f\u00fcm\u00fc ortalama 10 y\u0131l (8.1-12.6) s\u00fcrmektedir. \u00b7 Normale d\u00f6nme, CIN1 vakalar\u0131n\u0131n %60\u0131nda, CIN2lerin ise %40\u0131nda g\u00f6r\u00fclmektedir. 2. HPV-DNA testi kimlere yap\u0131lmal\u0131d\u0131r? 1. Aktif&hellip;<\/p>\n","protected":false},"author":1,"featured_media":452,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-56","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"http:\/\/www.filiptashan.com\/wp-json\/wp\/v2\/pages\/56","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.filiptashan.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/www.filiptashan.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/www.filiptashan.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.filiptashan.com\/wp-json\/wp\/v2\/comments?post=56"}],"version-history":[{"count":2,"href":"http:\/\/www.filiptashan.com\/wp-json\/wp\/v2\/pages\/56\/revisions"}],"predecessor-version":[{"id":309,"href":"http:\/\/www.filiptashan.com\/wp-json\/wp\/v2\/pages\/56\/revisions\/309"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.filiptashan.com\/wp-json\/wp\/v2\/media\/452"}],"wp:attachment":[{"href":"http:\/\/www.filiptashan.com\/wp-json\/wp\/v2\/media?parent=56"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}